The most commonly reported side effects of technetium tc-99m depreotide include radioisotope scan abnormal, based on 1 FDA adverse event reports from 2025 to 2025.
Percentages show how often each reaction appears relative to total reports for technetium tc-99m depreotide.
These are voluntary reports and do not establish that technetium tc-99m depreotide caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
Other drugs that appear in adverse event reports alongside technetium tc-99m depreotide. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
0.0% of technetium tc-99m depreotide adverse event reports involve female patients and 100.0% involve male patients. The largest age group is adult at 100%. These figures reflect who reports side effects, not underlying risk.
Sex
Age group
Conditions and purposes for which patients were taking technetium tc-99m depreotide when the adverse event was reported.
Technetium Tc-99m Depreotide is sold under the brand name Neo Tect Kit.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.